18
Participants
Start Date
October 31, 2010
Primary Completion Date
December 31, 2014
Study Completion Date
September 22, 2015
Revlimid
"Stage I:~Cohort 1: RICE + Lenalidomide 10mg days 1-7 Cohort 2: RICE + Lenalidomide 15mg days 1-7 Cohort 3: RICE + Lenalidomide 20mg days 1-7 Cohort 4: RICE + Lenalidomide 25mg days 1-7~Stage II:~RICE + Lenalidomide at the MTD days 1-7~Stage III:~Lenalidomide 25mg days 1-21 every 28 days"
Duke University Medical Center, Durham
John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
Collaborators (1)
Celgene Corporation
INDUSTRY
Hackensack Meridian Health
OTHER